Swedish Orphan Biovitrum AB (publ) (BIOVF)
USD 28.62
(0.0%)
USD 28.62
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.47 Billion | 4.66 Billion | 5.47 Billion | 5.21 Billion | 3.63 Billion | 2.09 Billion |
| Net Income | 2.4 Billion | 3.32 Billion | 3.29 Billion | 3.24 Billion | 3.3 Billion | 2.41 Billion |
| Depreciation & Amortization | 3.16 Billion | 2.41 Billion | 2 Billion | 2.02 Billion | 1.58 Billion | 484.57 Million |
| Deferred income taxes | -298 Million | -268 Million | -154 Million | 367 Million | 744 Million | -103.4 Million |
| Stock-based compensation | 298 Million | 268 Million | 154 Million | 114 Million | 80 Million | 46 Million |
| Change in working capital | -1.16 Billion | -806 Million | 1.11 Billion | -184 Million | -1.66 Billion | -250.46 Million |
| Other non-cash items | 53 Million | -269 Million | -945 Million | -351 Million | -417 Million | -503.91 Million |
| Investing Cash Flow | -21.9 Billion | -1.47 Billion | -367 Million | -3.96 Billion | -21.68 Billion | -575.53 Million |
| Investments in PPE | -4.94 Billion | -1.47 Billion | -370 Million | -3.85 Billion | -9.74 Billion | -577.87 Million |
| Acquisitions | -16.96 Billion | - | 3 Million | 8 Million | -12.88 Billion | 3.22 Million |
| Investment purchases | - | - | - | -120 Million | - | -700 Thousand |
| Sales/Maturities of investments | - | - | - | -8 Million | - | - |
| Other Investing Activities | -4.53 Billion | -1.4 Billion | -320 Million | 8 Million | 941 Million | 3.04 Million |
| Financing Cash Flow | 17.01 Billion | -2.99 Billion | -4.47 Billion | -1.57 Billion | 15.78 Billion | -2.05 Million |
| Debt repayment | -11.24 Billion | -16.09 Billion | -18.19 Billion | -15.02 Billion | -15.78 Billion | -2.05 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.12 Billion | 89 Million | - | - | - | - |
| Other Financing Activities | -203 Million | 13.1 Billion | 13.71 Billion | 13.45 Billion | 31.56 Billion | - |
| Accounts receivables | -901 Million | -1.98 Billion | 452 Million | 175 Million | -2.42 Billion | -678.93 Million |
| Accounts payables | -546 Million | 763 Million | 980 Million | 947 Million | 1.22 Billion | 659.3 Million |
| Inventory | 286 Million | 413 Million | -318 Million | -1.3 Billion | -459 Million | -230.84 Million |
| Other working capital | -546 Million | 1 Million | 980 Million | 1.06 Billion | 1.22 Billion | -19.62 Million |
| Cash at beginning of period | 1.36 Billion | 1.04 Billion | 404 Million | 737 Million | 2.99 Billion | 1.47 Billion |
| Cash at end of period | 904 Million | 1.36 Billion | 1.04 Billion | 404 Million | 737 Million | 2.99 Billion |
| Capital Expenditure | -4.94 Billion | -1.47 Billion | -370 Million | -3.85 Billion | -9.74 Billion | -577.87 Million |
| Effect of forex changes on cash | -35 Million | 119 Million | 12 Million | -13 Million | 9 Million | 7.38 Million |
| Net cash flow / Change in cash | -457 Million | 316 Million | 641 Million | -333 Million | -2.26 Billion | 1.52 Billion |
| Free Cash Flow | -473 Million | 3.18 Billion | 5.1 Billion | 1.36 Billion | -6.11 Billion | 1.51 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.71 Billion | 224 Million | 982 Million | 1.02 Billion | 2.4 Billion | 116 Million |
| Depreciation & Amortization | 924 Million | 915 Million | 909 Million | 997 Million | 3.16 Billion | 936 Million |
| Deferred income taxes | - | - | - | -298 Million | -298 Million | - |
| Stock-based compensation | 59 Million | - | - | 298 Million | 298 Million | - |
| Change in working capital | -1.65 Billion | 1.12 Billion | 472 Million | -824 Million | -1.16 Billion | 57 Million |
| Other non-cash items | 157 Million | 1.89 Billion | 387 Million | -127 Million | 53 Million | -51 Million |
| Investing Cash Flow | -2.2 Billion | -43 Million | -745 Million | -458 Million | -21.9 Billion | -414 Million |
| Investments in PPE | -2.18 Billion | -43 Million | -745 Million | -458 Million | -4.94 Billion | -414 Million |
| Acquisitions | - | - | - | - | -16.96 Billion | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.18 Billion | -1 Million | -719 Million | -224 Million | -4.53 Billion | -312 Million |
| Financing Cash Flow | 860 Million | -2.04 Billion | -1.86 Billion | -358 Million | 17.01 Billion | -774 Million |
| Debt repayment | -698 Million | -2.02 Billion | -1.76 Billion | -122 Million | -11.24 Billion | -6.77 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 136 Million | 39 Million | 55 Million | 50 Million | 6.12 Billion | 5.96 Billion |
| Other Financing Activities | 26 Million | -12 Million | -119 Million | -244 Million | -203 Million | 41 Million |
| Accounts receivables | - | - | - | -900 Million | -901 Million | - |
| Accounts payables | - | - | - | -1 Million | -546 Million | - |
| Inventory | - | - | - | 286 Million | 286 Million | - |
| Other working capital | -1.65 Billion | 1.12 Billion | 472 Million | -209 Million | -546 Million | 57 Million |
| Cash at beginning of period | 779 Million | 527 Million | 904 Million | 678 Million | 1.36 Billion | 790 Million |
| Cash at end of period | 594 Million | 779 Million | 527 Million | 904 Million | 904 Million | 678 Million |
| Capital Expenditure | -2.18 Billion | -43 Million | -745 Million | -458 Million | -4.94 Billion | -414 Million |
| Effect of forex changes on cash | -45 Million | 8 Million | -24 Million | -30 Million | -35 Million | 17 Million |
| Net cash flow / Change in cash | -185 Million | 252 Million | -377 Million | 226 Million | -457 Million | -112 Million |
| Free Cash Flow | -979 Million | 2.28 Billion | 1.51 Billion | 614 Million | -473 Million | 644 Million |
KIRLOSBROS
EVER
SUVIDHAA
ZFCVINDIA
KASH
BRS